arrow
M

Min Zhang

shanxi bethune hospital
H指数:28
被引数:3,195

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combined FXIII-C3 autoantibodies elicit bleeding and complement dysfunction in autoimmune FXIII deficiency

联合FXIII-C3自身抗体可引发出血和补体功能障碍,导致自身免疫性FXIII缺乏症

2026-02-020
OA
PHGDH-Dependent Serine Metabolism in Astrocytes: A Key Regulator of Oxidative Stress and Pyroptosis in Cerebral Ischemia-Reperfusion Injury

星形胶质细胞中PHGDH依赖性丝氨酸代谢:脑缺血再灌注损伤中氧化应激和焦亡的关键调节因子

2025-11-290
OAAI
A First-in-Class JAK/ROCK Inhibitor, Rovadicitinib in Patients with Myelofibrosis who were Refractory or Relapsed or Intolerant to Ruxolitinib: A Single-Arm, Multicenter, Open-Label, Phase Ib Study

一款首创的JAK/ROCK抑制剂Rovadicitinib,用于对Ruxolitinib耐药或复发或不能耐受的骨髓纤维化患者:一项单臂、多中心、开放标签、 Ib期研究

2025-08-050
PRE
Associations of urinary biomarkers of exposure to drinking-water disinfection by-products with haematological parameters and systemic inflammation indices among women undergoing assisted reproductive technology treatment

饮用 water disinfection by-products 暴露的尿液生物标志物与接受辅助生殖技术治疗女性的血液学参数及全身炎症指标的相关性

2025-07-100
PRE
Optimizing MR-based attenuation correction in hybrid PET/MR using deep learning: validation with a flatbed insert and consistent patient positioning

基于深度学习的混合PET/MR中MR依赖型衰减校正的优化:使用平面插入物和一致的患者定位进行验证

2025-02-060
PRE
Efficacy and Safety of Single-Dose Versus Split-Dose Mecapegfilgrastim with Etoposide for Autologous Peripheral Blood Stem Cell Mobilization: A Prospective, Randomized Clinical Trial

单剂量与分次剂量Mecapegfilgrastim联合依托泊苷用于自体外周血干细胞动员的疗效与安全性:一项前瞻性、随机临床试验

BLOOD
IF23.1
2024-11-050
PRE